Condition: Type 1 Diabetes (T1D) · Pre Diabetes · Sponsor: INNODIA iVZW
The purpose of INNODIA DETECT is to identify people who are at increased risk of developing T1D. Investigators are doing this by testing for markers in the blood (autoantibodies) that tell them an individuals risk of getting T1D in the future. What is Type 1 Diabetes (T1D)? T1D is a serious disease where the blood glucose (sugar) level is too high because the body cannot make a hormone called insulin. This happens when the body's immune system attacks the cells in the pancreas that make insulin (called beta cells), meaning that insulin production stops. This is harmful to the body as insulin does an essential job. It allows the glucose in the blood to enter cells and fuel the body, resulting in a lowering of the blood glucose level. What are Autoantibodies? T1D autoantibodies are markers found in the blood that indicate that the destruction of insulin producing cells has begun. The risk of developing T1D increases with the number of autoantibodies detected. People who have 1 autoantibody detected in their blood are at increased risk of developing T1D. The presence of 2 or more autoantibodies indicates that T1D is present but the individual does not show any signs or symptoms yet. However, these autoantibodies can be present for many years before someone develops symptoms of T1D. They often appear in the first few years of life. The investigators are asking children and adults across Europe, aged between 1 and 45 years, who have either a family member (parent, child, fu…
This description comes directly from the study's public registry record.
Laura Moreno Belmonte · +393889544246 · laura.moreno@innodia.org
Program Manager · detect@innodia.org
Always discuss trial participation with your own doctor first.
| Medical University of Vienna | Vienna, Austria | Recruiting |
| Katholieke Universiteit Leuven | Leuven, Belgium | Recruiting |
| Motol University Hospital | Prague, Czechia | Recruiting |
| Angers University Hospital Center (CHU Angers) | Angers, France | Recruiting |
| Nice-Lenval Pediatric Hospitals | Nice, France | Recruiting |
| Hôpital Pitié-Salpêtrière | Paris, France | Recruiting |
| Hôpital Européen Georges-Pompidou | Paris, France | Recruiting |
| Hôpital Necker-Enfants Malades | Paris, France | Recruiting |
| Robert Debre University Hospital | Paris, France | Recruiting |
| Institut National de la Santé et de la Recherche Médicale | Paris, France | Recruiting |
| CHRU de Nancy Hôpital de Brabois Enfant | Vandœuvre-lès-Nancy, France | Recruiting |
| Kompetenzzentrum Diabetes Karlsburg | Greifswald, Germany | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07118098